about
Lorcaserin: drug profile and illustrative model of the regulatory challenges of weight-loss drug developmentNew obesity classification criteria as a tool for bariatric surgery indicationObesity and colorectal cancer: role of adipokines in tumor initiation and progressionCardiac adipose tissue and its relationship to diabetes mellitus and cardiovascular diseaseHigh pericardial and peri-aortic adipose tissue burden in pre-diabetic and diabetic subjectsBariatric endocrinology: principles of medical practice.HIV protease inhibitors disrupt lipid metabolism by activating endoplasmic reticulum stress and inhibiting autophagy activity in adipocytesLorcaserin and adiposopathy: 5-HT2c agonism as a treatment for 'sick fat' and metabolic disease.Microarray evidences the role of pathologic adipose tissue in insulin resistance and their clinical implications.ER Stress and Lipid Metabolism in Adipocytes.Body mass index and musculoskeletal pain: is there a connection?Origins of metabolic complications in obesity: adipose tissue and free fatty acid trafficking.Cross-Sectional Associations of Computed Tomography (CT)-Derived Adipose Tissue Density and Adipokines: The Framingham Heart Study.Adiposopathy and bariatric surgery: is 'sick fat' a surgical disease?Adiposopathy, "sick fat," Ockham's razor, and resolution of the obesity paradox.Lifestyle-induced decrease in fat mass improves adiponectin secretion in obese adultsPhentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.Adiposopathy and thyroid disease: tracing the pathway to cardiovascular risk.Veganism Is a Viable Alternative to Conventional Diet Therapy for Improving Blood Lipids and Glycemic Control.Main characteristics of metabolically obese normal weight and metabolically healthy obese phenotypes.Effects of endurance training on autophagy and apoptotic signaling in visceral adipose tissue of prolonged high fat diet-fed rats.Organic fitness: physical activity consistent with our hunter-gatherer heritage.
P2860
Q22241480-D1053521-4932-43F4-A1BC-ADBAA4C15E6AQ26774656-B22DF3AE-A18D-4EAD-AF89-72C6D770A765Q26853740-81189BE4-3FEE-401A-AD98-1E05270E6A85Q26991652-9AA10E1F-0488-4AF5-8485-576129CF58B6Q31150510-F06D224B-3A9A-4A5F-A681-2605B3751910Q33677790-BFCB9650-85EC-455D-92A3-A13CDBD3A368Q34637857-8A9FEFA5-892F-4EC0-9241-889C12589C24Q34659424-8B6D0C26-75C6-4CBD-BEAE-29B81A69ED54Q34974769-8B509C13-6E24-4B52-A3E1-1E64165F756BQ35779442-9C53DB5F-623A-42C5-8701-B91EBC271786Q36881224-CC6401DB-306B-49A2-BBC1-4E871E402A14Q37013861-A9F5CA73-40F5-4E87-9B6B-143167D4850FQ37090694-680A5C39-4861-4F53-BAA4-19CD1522F5D5Q37427308-4605F45A-F667-4B15-B096-0EE172C1C4AFQ37678834-6723C793-1372-4EE7-BB1B-D662E74DEDB8Q37710253-64ACB11B-A3DD-4A67-B605-215735EF7C0AQ37779809-2040DA06-E367-4449-9ADB-95C573A8C6DCQ38034811-4C9F8355-DC63-4F55-94EB-97E7D2B36AF2Q38219695-EF4405A2-DF05-4BB9-8329-9A02655F54CAQ38507577-59B9EA8E-1AA8-4465-B935-51563C52ECD8Q38683081-472C738B-7834-4886-9FC9-D7B894CE2C57Q47336390-304DC136-4950-4BAA-967D-792507733190
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Is adiposopathy (sick fat) an endocrine disease?
@ast
Is adiposopathy (sick fat) an endocrine disease?
@en
Is adiposopathy (sick fat) an endocrine disease?
@nl
type
label
Is adiposopathy (sick fat) an endocrine disease?
@ast
Is adiposopathy (sick fat) an endocrine disease?
@en
Is adiposopathy (sick fat) an endocrine disease?
@nl
prefLabel
Is adiposopathy (sick fat) an endocrine disease?
@ast
Is adiposopathy (sick fat) an endocrine disease?
@en
Is adiposopathy (sick fat) an endocrine disease?
@nl
P2093
P2860
P921
P1476
Is adiposopathy (sick fat) an endocrine disease?
@en
P2093
A B Schorr
A E Kitabchi
D A Bergman
H W Rodbard
J M González-Campoy
P2860
P304
P356
10.1111/J.1742-1241.2008.01848.X
P407
P5008
P577
2008-10-01T00:00:00Z